- Home
- Novo Nordisk A S
Insider Trading History of Novo Nordisk A S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Novo Nordisk A S since 2010.
The trader's CIK number is 353278.
At the time of the last reporting, Novo Nordisk A S was the 10% Owner of Aradigm Corp. (stock ticker symbol ARDM).
Also see all insider trading activities at Aradigm Corp.
Note that in the past
NOVO NORDISK A S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Aradigm Corp (ARDM) by Novo Nordisk A S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | ARDM | 26,000,000 | $0 | 1,369,550 | $229,008 | 0 | $0 |
Yearly summary of insider trading at Zymogenetics Inc (ZGEN) by Novo Nordisk A S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | ZGEN | 1,250,000 | $7,500,000 | 22,143,320 | $215,897,370 | 0 | $0 |
Insider trading activities at 2 companies by Novo Nordisk A S:
1. Aradigm Corp (ARDM)
2. Zymogenetics Inc (ZGEN)
Table 1. Insider trading of Aradigm Corp (ARDM) by Novo Nordisk A S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-11-05 | ARDM | Sale | 401,469 | .17 | 68,651 |
| 2010-11-04 | ARDM | Sale | 225,000 | .17 | 38,250 |
| 2010-11-03 | ARDM | Sale | 250,000 | .16 | 40,750 |
| 2010-11-02 | ARDM | Sale | 256,675 | .17 | 42,351 |
| 2010-11-01 | ARDM | Sale | 236,406 | .17 | 39,006 |
| 2010-09-16 | ARDM | Buy | 26,000,000 | .00 | 0 |
Table 2. Insider trading of Zymogenetics Inc (ZGEN) by Novo Nordisk A S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-10-08 | ZGEN | Sale | 22,143,320 | 9.75 | 215,897,370 |
| 2010-01-07 | ZGEN | Buy | 1,250,000 | 6.00 | 7,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Novo Nordisk A S
(10% Owner of Aradigm Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.